FISABIO HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE

FISABIO HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE

FISABIO
HOSPITAL GENERAL
UNIVERSITARIO DE ALICANTE
NEUROPHARMACOLOGY
APPLIED TO PAIN AND
FUNCTIONAL DIVERSITY/NED
HEAD OF RESEARCH SECTION
DR ANA MARÍA PEIRÓ PEIRÓ
[email protected] / PEIRO_ [email protected]
EDIFICIO GRIS, 5ª PLANTA
PINTOR BAEZA,12 / 03010 ALICANTE / SPAIN
We are a group of professionals who are
mostly affiliated to the Department of Health
of Alicante-Hospital General, and interested in
the study and treatment of pain with the objective of improving the quality of life of those who
suffer it. We are firmly committed to individuals
experiencing pain and their families.
We support actions that promote the use
of scientifically validated treatments, generally
known as evidence-based medicine, and strive
to contribute to the identification and comparison of techniques and strategies helping
improve the quality of life of individuals with
chronic pain.
OBJECTIVES
The pain physiopathology and treatment research group was
born in 2011, coinciding with the incorporation of the group
coordinator (Dr Ana Peiró) to the Pain Unit of the Department
of Anaesthesiology and Reanimation. The unit consists of
basic and clinical researchers interested in the study of the
physiopathology, neuropharmacology and treatment of pain
from both clinical and preclinical perspectives. The group has a
dedicated space in the experimental laboratory of the Research
Unit and carries out investigations at the cellular and molecular
levels.
At the experimental laboratory, basic researchers (biologists
and pharmacists) and clinical researchers (pharmaceutical
physicians and anaesthesiologists) work together, contributing
their diverse knowledge and experience to the resolution of
proposed problems.
The information contributed by our studies is needed to
understand the cellular basis of higher functions of the brain.
This provides the foundation for the correct understanding of its
normal and pathological functioning in the context of medicine
and pain management with the ultimate goal of improving
quality of life in patients living with pain.
AREAS OF RESEARCH
02
FISABIO
NEUROPHARMACOLOGY APPLIED TO PAIN
AND FUNCTIONAL DIVERSITY/NED
AREA 1. Drug combinations used for the treatment of chronic pain.
Pharmacovigilance and cost-effectiveness studies.
AREA 2. Long-term safety in patients with pain receiving chronic treatment
with opioids. Dr Segura and DPharm Ajo.
AREA 3. Opioid dependence in chronic pain models.
AREA 4. Pharmacogenetics applied to pain management.
AREA 5. Treatment of refractory pain: interdisciplinary approach and
interventional techniques.
AREA 6. Chronobiology and sleep disorders in patients with pain.
AREA 7. Bioethics of opioid therapy for severe pain.
AREA 8. Education to promote improved management of severe pain with
opioid therapy.
FOR MORE INFORMATION ON FISABIO’S ACTIVITIES AND SERVICES:
W. FISABIO.SAN.GVA.ES / T. +34 961925700 / M. [email protected]
FUNDACIÓN PAR A EL FOMENTO DE L A INVESTIGACIÓN SANITARIA Y BIOMÉDIC A DE L A COMUNIDAD VALENCIANA (FISABIO) / AVENIDA DE C ATALUÑA, 21 / 46020 VALENCIA / SPAIN
THE ELABORATION OF THIS DOCUMENT HAS BEEN FUNDED BY THE PROJECT AFI-01/14, IN THE CONTEXT OF THE GRANTS FOR PARTICIPATION IN EUROPEAN COMMISSION RESEARCH PROGRAMMES ON HEALTH GIVEN BY THE CONSELLERIA DE SANITAT UNIVERSAL I
SALUT PÚBLICA OF THE GOVERNMENT OF VALENCIA FOR THE 2014-2015 FISCAL PERIOD.